Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Metabolic targeting of HIF-dependent glycolysis reduces lactate, increases oxygen consumption and enhances response to high-dose single-fraction radiotherapy in hypoxic solid tumors.

Leung E, Cairns RA, Chaudary N, Vellanki RN, Kalliomaki T, Moriyama EH, Mujcic H, Wilson BC, Wouters BG, Hill R, Milosevic M.

BMC Cancer. 2017 Jun 15;17(1):418. doi: 10.1186/s12885-017-3402-6.

2.

Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells.

Belcheva A, Irrazabal T, Robertson SJ, Streutker C, Maughan H, Rubino S, Moriyama EH, Copeland JK, Surendra A, Kumar S, Green B, Geddes K, Pezo RC, Navarre WW, Milosevic M, Wilson BC, Girardin SE, Wolever TMS, Edelmann W, Guttman DS, Philpott DJ, Martin A.

Cell. 2014 Jul 17;158(2):288-299. doi: 10.1016/j.cell.2014.04.051. Erratum in: Cell. 2014 Oct 9;159(2):456.

3.

Optical glucose analogs of aminolevulinic acid for fluorescence-guided tumor resection and photodynamic therapy.

Moriyama EH, Cao W, Liu TW, Wang HL, Kim PD, Chen J, Zheng G, Wilson BC.

Mol Imaging Biol. 2014 Aug;16(4):495-503. doi: 10.1007/s11307-013-0687-y.

PMID:
24323192
4.

Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1.

Wang Y, Roche O, Xu C, Moriyama EH, Heir P, Chung J, Roos FC, Chen Y, Finak G, Milosevic M, Wilson BC, Teh BT, Park M, Irwin MS, Ohh M.

Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):4892-7. doi: 10.1073/pnas.1112129109. Epub 2012 Mar 12.

5.

Uroporphyrinogen decarboxylase is a radiosensitizing target for head and neck cancer.

Ito E, Yue S, Moriyama EH, Hui AB, Kim I, Shi W, Alajez NM, Bhogal N, Li G, Datti A, Schimmer AD, Wilson BC, Liu PP, Durocher D, Neel BG, O'Sullivan B, Cummings B, Bristow R, Wrana J, Liu FF.

Sci Transl Med. 2011 Jan 26;3(67):67ra7. doi: 10.1126/scitranslmed.3001922.

6.

Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virus.

Roos FC, Roberts AM, Hwang II, Moriyama EH, Evans AJ, Sybingco S, Watson IR, Carneiro LA, Gedye C, Girardin SE, Ailles LE, Jewett MA, Milosevic M, Wilson BC, Bell JC, Der SD, Ohh M.

EMBO Mol Med. 2010 Jul;2(7):275-88. doi: 10.1002/emmm.201000081.

7.

Continuous docetaxel chemotherapy improves therapeutic efficacy in murine models of ovarian cancer.

De Souza R, Zahedi P, Moriyama EH, Allen CJ, Wilson BC, Piquette-Miller M.

Mol Cancer Ther. 2010 Jun;9(6):1820-30. doi: 10.1158/1535-7163.MCT-10-0249. Epub 2010 Jun 8.

8.

Drug and light dose responses to focal photodynamic therapy of single blood vessels in vivo.

Khurana M, Moriyama EH, Mariampillai A, Samkoe K, Cramb D, Wilson BC.

J Biomed Opt. 2009 Nov-Dec;14(6):064006. doi: 10.1117/1.3262521.

9.

Oxygen-independent degradation of HIF-alpha via bioengineered VHL tumour suppressor complex.

Sufan RI, Moriyama EH, Mariampillai A, Roche O, Evans AJ, Alajez NM, Vitkin IA, Yang VX, Liu FF, Wilson BC, Ohh M.

EMBO Mol Med. 2009 Apr;1(1):66-78. doi: 10.1002/emmm.200900004.

10.

In vivo effects of low level laser therapy on inducible nitric oxide synthase.

Moriyama Y, Nguyen J, Akens M, Moriyama EH, Lilge L.

Lasers Surg Med. 2009 Mar;41(3):227-31. doi: 10.1002/lsm.20745.

PMID:
19291752
11.

Proof-of-principle demonstration of a Mueller matrix decomposition method for polarized light tissue characterization in vivo.

Wood MF, Ghosh N, Moriyama EH, Wilson BC, Vitkin IA.

J Biomed Opt. 2009 Jan-Feb;14(1):014029. doi: 10.1117/1.3065545.

12.

Efficacy assessment of sustained intraperitoneal paclitaxel therapy in a murine model of ovarian cancer using bioluminescent imaging.

Vassileva V, Moriyama EH, De Souza R, Grant J, Allen CJ, Wilson BC, Piquette-Miller M.

Br J Cancer. 2008 Dec 16;99(12):2037-43. doi: 10.1038/sj.bjc.6604803. Epub 2008 Nov 25.

13.

Intravital high-resolution optical imaging of individual vessel response to photodynamic treatment.

Khurana M, Moriyama EH, Mariampillai A, Wilson BC.

J Biomed Opt. 2008 Jul-Aug;13(4):040502. doi: 10.1117/1.2965545.

14.

Speckle variance detection of microvasculature using swept-source optical coherence tomography.

Mariampillai A, Standish BA, Moriyama EH, Khurana M, Munce NR, Leung MK, Jiang J, Cable A, Wilson BC, Vitkin IA, Yang VX.

Opt Lett. 2008 Jul 1;33(13):1530-2.

PMID:
18594688
15.

The influence of hypoxia on bioluminescence in luciferase-transfected gliosarcoma tumor cells in vitro.

Moriyama EH, Niedre MJ, Jarvi MT, Mocanu JD, Moriyama Y, Subarsky P, Li B, Lilge LD, Wilson BC.

Photochem Photobiol Sci. 2008 Jun;7(6):675-80. doi: 10.1039/b719231b. Epub 2008 Apr 8.

PMID:
18528551
16.

Tensile bond strength and SEM analysis of enamel etched with Er:YAG laser and phosphoric acid: a comparative study in vitro.

Sasaki LH, Lobo PD, Moriyama Y, Watanabe IS, Villaverde AB, Tanaka CS, Moriyama EH, Brugnera A Jr.

Braz Dent J. 2008;19(1):57-61.

17.

Optical molecular imaging: from single cell to patient.

Moriyama EH, Zheng G, Wilson BC.

Clin Pharmacol Ther. 2008 Aug;84(2):267-71. doi: 10.1038/clpt.2008.58. Epub 2008 Apr 2.

PMID:
18388867
18.

Diblock copolymer micelles deliver hydrophobic protoporphyrin IX for photodynamic therapy.

Li B, Moriyama EH, Li F, Jarvi MT, Allen C, Wilson BC.

Photochem Photobiol. 2007 Nov-Dec;83(6):1505-12.

PMID:
18028227
19.

Imaging the Modulation of Adenoviral Kinetics and Biodistribution for Cancer Gene Therapy.

Mocanu JD, Yip KW, Alajez NM, Shi W, Li JH, Lunt SJ, Moriyama EH, Wilson BC, Milosevic M, Lo KW, van Rooijen NV, Busson P, Bastianutto C, Liu FF.

Mol Ther. 2007 May;15(5):921-929. doi: 10.1038/mt.sj.6300119. Epub 2016 Dec 7.

PMID:
28182894
20.

Imaging the modulation of adenoviral kinetics and biodistribution for cancer gene therapy.

Mocanu JD, Yip KW, Alajez NM, Shi W, Li JH, Lunt SJ, Moriyama EH, Wilson BC, Milosevic M, Lo KW, van Rooijen N, Busson P, Bastianutto C, Liu FF.

Mol Ther. 2007 May;15(5):921-9. Epub 2007 Mar 13.

21.

In vivo study of the inflammatory modulating effects of low-level laser therapy on iNOS expression using bioluminescence imaging.

Moriyama Y, Moriyama EH, Blackmore K, Akens MK, Lilge L.

Photochem Photobiol. 2005 Nov-Dec;81(6):1351-5.

PMID:
16076245
22.

Fluorescence image-guided brain tumour resection with adjuvant metronomic photodynamic therapy: pre-clinical model and technology development.

Bogaards A, Varma A, Zhang K, Zach D, Bisland SK, Moriyama EH, Lilge L, Muller PJ, Wilson BC.

Photochem Photobiol Sci. 2005 May;4(5):438-42. Epub 2005 Apr 14.

PMID:
15875077
23.

Combined in vivo bioluminescence and fluorescence imaging for cancer gene therapy.

Mocanu JD, Moriyama EH, Chia MC, Li JH, Yip KW, Huang DP, Bastianutto C, Wilson BC, Liu FF.

Mol Imaging. 2004 Oct;3(4):352-5.

PMID:
15802052
24.

Bioluminescence imaging of the response of rat gliosarcoma to ALA-PpIX-mediated photodynamic therapy.

Moriyama EH, Bisland SK, Lilge L, Wilson BC.

Photochem Photobiol. 2004 Sep-Oct;80(2):242-9.

PMID:
15362932
25.

Dentin evaluation after Nd:YAG laser irradiation using short and long pulses.

Moriyama EH, Zângaro RA, Villaverde AB, Lobo PD, Munin E, Watanabe IS, Júnior DR, Pacheco MT.

J Clin Laser Med Surg. 2004 Feb;22(1):43-50.

PMID:
15117486
26.

Optothermal transfer simulation in laser-irradiated human dentin.

Moriyama EH, Zangaro RA, Lobo PD, Villaverde AB, Pacheco MT, Watanabe IS, Vitkin A.

J Biomed Opt. 2003 Apr;8(2):298-302.

Supplemental Content

Loading ...
Support Center